Search - tctmd.com

Displaying 41 - 60 of 136

Sort: Relevancy | Date

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TCT 2019

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Focus FMR: Trial Data, Patient Selection, and Synergistic Therapies

Presenter: Michael Mack

September 28, 2019

Presentation TCT 2019

Critical Analysis of De Novo and ISR Clinical Trial Data

Presenter: Fernando Alfonso

September 28, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Session II: Clinical Research and Practice in Percutaneous Coronary Intervention - “DEFINITION” of Contemporary Bifurcation Treatment: Current Evidence and Future Trials

Presentation TCT 2019

“DEFINITION” of Contemporary Bifurcation Treatment: Current Evidence and Future Trials

Presenter: Shao-Liang Chen

September 25, 2019

Presentation TCT 2018

Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years

Presenter: Jay S. Giri, Sahil A. Parikh

September 22, 2018

Presentation SCAD 2018

How should we design future SCAD trials?

Presenter: Karin H Humphries

September 08, 2018

Presentation ESC 2018

FUnctional Testing Underlying REvascularization The FUTURE trial

Presenter: Gilles Rioufol

August 26, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation CIT 2018

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 23, 2018

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Advertisement

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Focus FMR: Trial Data, Patient Selection, and Synergistic Therapies

Critical Analysis of De Novo and ISR Clinical Trial Data

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

“DEFINITION” of Contemporary Bifurcation Treatment: Current Evidence and Future Trials

Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years

How should we design future SCAD trials?

FUnctional Testing Underlying REvascularization The FUTURE trial

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

UK All-Comers

Evolut R Low-Risk

Partner 3 Low-Risk

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content